Our study demonstrated that surgical intraoperative time was equal for both laparoscopic and robotic-assisted approaches for the appendectomies and cholecystectomies, but post-operative time and recovery was significantly shorter for the robotic approach.
This study was unique in that two surgeons identical in skill level evaluated the operative duration of laparoscopic and robotic approaches, as well as the post-operative length of stay. Intraoperative time can be considered a surrogate of utilization of OR services, mainly special supplies and specialized OR staff. Other studies have also demonstrated better clinical outcomes for robotic-assisted procedures, including estimated blood loss and post-operative morbidities.13–15
In our study, peri-operative care was primarily provided by hospitalists who were dedicated to patient care and were strongly encouraged to discharge patients, with surgeon approval, in an expedient fashion. This fact, along with the retrospective design of this study, allowed us to compare the two surgical approaches without surgeon bias toward either procedure type.
All robotic-assisted surgeries in this study were all performed exclusively by Surgeon B, a completely trained robotic surgeon. It is not clear whether robotic training improves laparoscopic skills; however, we made the assumption that identical surgeons in skill level would have equal laparoscopic skills. If true, this could have financial implications for credentialing of better, faster surgeons; however, this may mean an increased likelihood for a preference for laparoscopic surgery, which in turn may lead to more intraoperative conversions to open procedure.
The findings of this study were clinical, not financial, in regard to operative and post-operative time. The saving of time associated with the robotic approach may reflect better clinical outcomes such as recovery and reduced risks of complication.
In this study, the risk of conversion to open procedure was significantly higher for the laparoscopic group, and this conversion rate may reflect a more technically difficult procedure. Moreover, this may indicate that the robotic approach is a more versatile technique for handling technically difficult cases and may reduce the risk of conversion to open procedures.
One limitation of this study may have been that because more robotic cholecystectomies were performed than laparoscopic, more difficult cases may have been left to laparoscopic surgeon, increasing the risk of conversion to open procedures in this group. However, we believe that this did not affect our results, as the same surgeons and hospitals enroll less patients in the robotic appendectomy group, and both had zero conversions to open procedures. Cases that were converted to open procedures only occurred in the laparoscopic group, which may support the notion that robotic surgery is a better platform to manage more difficult surgical cases.
Another limitation is the exclusion of the outliers. If outliers were included, data and conclusions would have been influenced by a few and we would strongly assume that being an outlier most likely is the result of other complex medical conditions not related to the surgical approach that the surgical intervention modality might not have affected the overall medical condition leading to being an outlier.
The robotic surgical platform has been FDA approved for clinical use in the United States for over two decades and has been increasing in use by general surgeons in recent years. Additionally, robotic appendectomies and cholecystectomies are very common and considered to require only entry-level robotic surgery skills. Moreover, many case reports have been published showing the benefits and risks of this surgical methodology; most have concluded that while visualization is improved with the binocular vision in robotic-assisted procedures, the operative time is longer and the cost per case is higher due to higher instrument costs and OR time.
To consider promoting robotic surgery as the gold standard approach, and to truly measure the cost savings of either procedure type, hospital systems must calculate global savings instead of single item savings, along with the readmission factor, the conversion factor, and the patient satisfaction and surveys and reputations.
The lower risk for conversion carried by the robotic-assisted approach is a very attractive point for patients to desire robotic surgery versus laparoscopic approach. Thus, in our opinion, it is a matter of short time before robotic surgery will become the gold standard, as clarity of evidence supporting superiority of clinical outcomes and length of stay will supersede costs of hospitalization, equipment, supplies, and specialized staff. Moreover, these costs should decrease over time.
Ultimately as physicians’ data supporting clinical and fiscal superiority for robotic surgery continue to tip the scale towards robotic surgery, hospital and healthcare systems may consider global savings including patients’ satisfactions as a tool to market to patients. Robotic surgery seems to be superior in the risk to conversion to open procedure and shorter hospital stay.
This study did not examine clinical outcomes. Future studies should examine additional clinical outcomes, like estimated blood loss, post-operative wound infections and all surgical complications.